Lepu Biopharma Co., Ltd. (2157.HK)

HKD 3.31

(0.91%)

Net Debt Summary of Lepu Biopharma Co., Ltd.

  • Lepu Biopharma Co., Ltd.'s latest annual net debt in 2023 was 320.8 Million CNY , up 1434.45% from previous year.
  • Lepu Biopharma Co., Ltd.'s latest quarterly net debt in 2024 Q2 was 215.97 Million CNY , up 20.96% from previous quarter.
  • Lepu Biopharma Co., Ltd. reported annual net debt of 20.9 Million CNY in 2022, down -88.39% from previous year.
  • Lepu Biopharma Co., Ltd. reported annual net debt of 180.09 Million CNY in 2021, up 190.14% from previous year.
  • Lepu Biopharma Co., Ltd. reported quarterly net debt of 215.97 Million CNY for 2024 Q2, up 20.96% from previous quarter.
  • Lepu Biopharma Co., Ltd. reported quarterly net debt of 320.8 Million CNY for 2023 Q4, up 9.69% from previous quarter.

Annual Net Debt Chart of Lepu Biopharma Co., Ltd. (2023 - 2019)

Historical Annual Net Debt of Lepu Biopharma Co., Ltd. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 320.8 Million CNY 1434.45%
2022 20.9 Million CNY -88.39%
2021 180.09 Million CNY 190.14%
2020 -199.78 Million CNY -151.36%
2019 388.99 Million CNY 0.0%

Peer Net Debt Comparison of Lepu Biopharma Co., Ltd.

Name Net Debt Net Debt Difference
Uni-Bio Science Group Limited -76.36 Million HKD 520.075%
CK Life Sciences Int'l., (Holdings) Inc. 5.26 Billion HKD 93.909%